World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
123
Citations
72594
World Ranking
3289
National Ranking
1812

Overview

Mark J. Sarnak is affiliated with Tufts Medical Center in the United States. Their research is primarily situated within the field of Medicine, with a strong focus on Nephrology as a subfield. Additional areas of study include Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Psychiatry and Mental Health, and Endocrinology, Diabetes and Metabolism.

The scientist's main research topics revolve around medical conditions and treatments related to kidney and cardiovascular health. These topics include Dialysis and Renal Disease Management, Chronic Kidney Disease and Diabetes, Blood Pressure and Hypertension Studies, Renal and Vascular Pathologies, Heart Failure Treatment and Management, Parathyroid Disorders and Treatments, as well as Dementia and Cognitive Impairment Research.

Mark J. Sarnak has contributed to multiple recent scholarly papers, some of which are:

  • Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease (2021), published in Kidney International
  • Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes (2023), published in JAMA
  • Association of Multiple Plasma Biomarker Concentrations with Progression of Prevalent Diabetic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study (2020), published in Journal of the American Society of Nephrology
  • Chronic Kidney Disease and Cerebrovascular Disease (2021), published in Stroke
  • Evaluation of Screening Tests for Cognitive Impairment in Patients Receiving Maintenance Hemodialysis (2020), published in Journal of the American Society of Nephrology

The scientist's research is frequently published in journals such as:

  • Journal of the American Society of Nephrology (18 publications)
  • American Journal of Kidney Diseases (10 publications)
  • Kidney International (3 publications)
  • Kidney International Reports (3 publications)
  • PLoS ONE (3 publications)

Mark J. Sarnak collaborates regularly with a number of coauthors. Frequent collaborators include:

  • Joachim H. Ix (33 coauthored works)
  • Michael G. Shlipak (28 coauthored works)
  • Ronit Katz (23 coauthored works)
  • Orlando M. Gutiérrez (22 coauthored works)
  • Chirag R. Parikh (13 coauthored works)

Best Publications

  • Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

    Mark J. Sarnak;Andrew S. Levey;Anton C. Schoolwerth;Josef Coresh

  • Clinical epidemiology of cardiovascular disease in chronic renal disease.

    Robert N. Foley;Patrick S. Parfrey;Mark J. Sarnak

  • Cystatin C and the risk of death and cardiovascular events among elderly persons.

    Michael G. Shlipak;Mark J. Sarnak;Ronit Katz;Linda F. Fried

  • Epidemiology of cardiovascular disease in chronic renal disease.

    Foley Rn;Parfrey Ps;Sarnak Mj

  • CHRONIC KIDNEY DISEASE AS A RISK FACTOR FOR CARDIOVASCULAR DISEASE AND ALL-CAUSE MORTALITY: A POOLED ANALYSIS OF COMMUNITY-BASED STUDIES

    Daniel E. Weiner;Hocine Tighiouart;Manish G. Amin;Paul C. Stark

  • Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options.

    Joachim Jankowski;Jürgen Floege;Danilo Fliser;Michael Böhm

  • Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients

    Alfred K. Cheung;Mark J. Sarnak;Guofen Yan;Johanna T. Dwyer

  • K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease

    Andrew S. Levey;Michael V. Rocco;Sharon Anderson;Sharon P. Andreoli

  • Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community.

    Guruprasad Manjunath;Hocine Tighiouart;Hassan N. Ibrahim;Bonnie MacLeod

  • Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction.

    Amin Al-Ahmad;William M Rand;Guruprasad Manjunath;Marvin A Konstam

  • Cystatin C versus creatinine in determining risk based on kidney function.

    Michael G. Shlipak;Kunihiro Matsushita;Johan Ärnlöv;Johan Ärnlöv;Lesley A. Inker

  • Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts

    Brad C. Astor;Kunihiro Matsushita;Ron T. Gansevoort;Marije Van Der Velde

  • Mortality caused by sepsis in patients with end-stage renal disease compared with the general population

    Mark J. Sarnak;Bertrand L. Jaber

  • Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data.

    Kunihiro Matsushita;Josef Coresh;Yingying Sang;John Chalmers

  • Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study.

    Alfred K. Cheung;Mark J. Sarnak;Guofen Yan;Michael Berkoben

  • Cardiovascular disease and chronic renal disease: a new paradigm.

    Mark J. Sarnak;Andrew S. Levey

  • KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease

    Alfred K. Cheung;Tara I. Chang;William C. Cushman;Susan L. Furth

  • Cystatin C and Prognosis for Cardiovascular and Kidney Outcomes in Elderly Persons without Chronic Kidney Disease

    Michael G. Shlipak;Ronit Katz;Mark J. Sarnak;Linda F. Fried

  • Multiple loci associated with indices of renal function and chronic kidney disease

    Anna Köttgen;Nicole L. Glazer;Abbas Dehghan;Shih Jen Hwang

  • Cystatin C and the Risk of Death and Cardiovascular Events Among Elderly Persons

    M.G. Shilpak;M.J. Sarnak;R. Katz

Frequent Co-Authors

Michael G. Shlipak
Michael G. Shlipak University of California, San Francisco
Ronit Katz
Ronit Katz University of Washington
Joachim H. Ix
Joachim H. Ix University of California, San Diego
Andrew S. Levey
Andrew S. Levey Tufts Medical Center
David S. Siscovick
David S. Siscovick University of Washington
Linda F. Fried
Linda F. Fried University of Pittsburgh
Anne B. Newman
Anne B. Newman University of Pittsburgh
Bryan Kestenbaum
Bryan Kestenbaum University of Washington
Ian H. de Boer
Ian H. de Boer University of Washington
Carmen A. Peralta
Carmen A. Peralta University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are considering studying Medicine in the USA, there are several flexible online options that can expand your qualifications or open new career pathways. From advanced nursing practice to specialized health administration, online degrees offer convenience alongside accredited training.

Those interested in top-level nursing roles should explore the cheapest online dnp programs, which prepare you for leadership in clinical practice or administration. For pharmacy careers, accredited online pharmacy schools let you earn your doctorate with greater schedule flexibility.

Digital solutions are transforming healthcare, making health informatics a fast-growing field. Online degrees in this area teach you to manage medical data and improve patient care through technology.

For those looking for quicker pathways, consider the financial and practical aspects of how much is medical billing and coding school. These programs can lead to stable careers in healthcare administration within a short timeframe.

Best Scientists Citing Mark J. Sarnak

Trending Scientists